ArticleInternational journal of molecular sciences2025
Alginate-Based Microparticles Containing Albumin and Doxorubicin: Nanoarchitectonics and Characterization.
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alginate-based microcapsules have gained considerable attention as drug delivery systems due to their biocompatibility, biodegradability, and ability to encapsulate therapeutic agents. In this study, microcapsules were synthesized by crosslinking with calcium ions, with albumin serving as a carrier for doxorubicin. The goal was to develop a stable system capable of controlled drug release under physiological conditions, with potential applications in cancer therapy. Sodium alginate was used as a base polymer, which formed a stable matrix after crosslinking with calcium ions. The resulting microcapsules showed a uniform size distribution in the microscale range. Analyses confirmed their stability in simulated physiological environments with minimal degradation. Observations revealed a homogeneous structure of the microcapsules, while incubation studies confirmed controlled drug release triggered by pH changes. The results indicate that alginate-albumin microcapsules can serve as an effective platform for drug delivery, especially in cancer therapy and other biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.